18F-fluorocholine PET-guided target volume delineation techniques for partial prostate re-irradiation in local recurrent prostate cancer

Radiotherapy and Oncology

Volumn 93, Issue 2, 2009, Pages 220-225

  Wang, Hui ^a   Vees, Hansjörg ^a   Miralbell, Raymond ^a   Wissmeyer, Michael ^a   Steiner, Charles ^a   Ratib, Osman ^a   Senthamizhchelvan, Srinivasan ^a   Zaidi, Habib ^a,b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

18F fluorocholine; Gross tumour volume; Image segmentation; PET CT; Recurrent prostate cancer

Indexed keywords

CONTRAST MEDIUM; FLUOROCHOLINE F 18; UNCLASSIFIED DRUG; CHOLINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FLUORINE; FLUOROCHOLINE; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SIZE; CLINICAL ARTICLE; HUMAN; IMAGE ANALYSIS; IMAGE INTENSIFIER; IRRADIATION; MALE; MEDICAL SPECIALIST; NUCLEAR MEDICINE; PHYSICIAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RECURRENT CANCER; REPEAT PROCEDURE; RETROSPECTIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; MIDDLE AGED; PROSTATE TUMOR; RADIATION DOSE; SCINTISCANNING; TUMOR RECURRENCE;

AGED; AGED, 80 AND OVER; CHOLINE; FLUORINE RADIOISOTOPES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 70350502585     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.08.037     Document Type: Article

References (34)

1. Kupelian P.A., Buchsbaum J.C., Patel C., et al. Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era. Int J Radiat Oncol Biol Phys 52 (2002) 704-711
2. Kuban D.A., Thames H.D., Levy L.B., et al. Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era. Int J Radiat Oncol Biol Phys 57 (2003) 915-928
3. Grossfeld G.D., Stier D.M., Flanders S.C., et al. Use of second treatment following definitive local therapy for prostate cancer: data from the caPSURE database. J Urol 160 (1998) 1398-1404
4. Nguyen P.L., D'Amico A.V., Lee A.K., and Suh W.W. Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature. Cancer 110 (2007) 1417-1428
5. Wise A.M., Stamey T.A., McNeal J.E., and Clayton J.L. Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. Urology 60 (2002) 264-269
6. Arora R., Koch M.O., Eble J.N., et al. Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate. Cancer 100 (2004) 2362-2366
7. Huang W.C., Kuroiwa K., Serio A.M., et al. The anatomical and pathological characteristics of irradiated prostate cancers may influence the oncological efficacy of salvage ablative therapies. J Urol 177 (2007) 1324-1329 quiz 1591
8. Pucar D., Hricak H., Shukla-Dave A., et al. Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence. Int J Radiat Oncol Biol Phys 69 (2007) 62-69
9. Apolo A.B., Pandit-Taskar N., and Morris M.J. Novel tracers and their development for the imaging of metastatic prostate cancer. J Nucl Med 49 (2008) 2031-2041
10. Cimitan M., Bortolus R., Morassut S., et al. [(18)F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients. Eur J Nucl Med Mol Imaging 33 (2006) 1387-1398
11. Husarik D.B., Miralbell R., Dubs M., et al. Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer. Eur J Nucl Med Mol Imaging 35 (2008) 253-263
12. Pouliot J., Kim Y., Lessard E., et al. Inverse planning for HDR prostate brachytherapy used to boost dominant intraprostatic lesions defined by magnetic resonance spectroscopy imaging. Int J Radiat Oncol Biol Phys 59 (2004) 1196-1207
13. 1H-spectroscopic MRI. Int J Radiat Oncol Biol Phys 65 (2006) 291-303
14. Zaidi H., Vees H., and Wissmeyer M. Molecular PET/CT imaging-guided radiation therapy treatment planning. Acad Radiol 16 (2009) 1108-1133
15. Steiner C., Vees H., Zaidi H., et al. Three-phase (18)F-fluorocholine PET/CT in the evaluation of prostate cancer recurrence. Nuklearmedizin 48 (2009) 1-9
16. Zaidi H, El Naqa I. PET-guided delineation of radiation therapy treatment volumes: A review of image segmentation techniques. Submitted.
17. Yaremko B., Riauka T., Robinson D., et al. Thresholding in PET images of static and moving targets. Phys Med Biol 50 (2005) 5969-5982
18. Hong R., Halama J., Bova D., Sethi A., and Emami B. Correlation of PET standard uptake value and CT window-level thresholds for target delineation in CT-based radiation treatment planning. Int J Radiat Oncol Biol Phys 67 (2007) 720-726
19. Schmid D.T., John H., Zweifel R., et al. Fluorocholine PET/CT in patients with prostate cancer: initial experience. Radiology 235 (2005) 623-628
20. 18F-fluorocholine. J Nucl Med 43 (2002) 92-96 Erratum in J Nucl Med 43(4):509
21. Graves E.E., Quon A., and Loo B.W. RT_Image: an open-source tool for investigating PET in radiation oncology. Technol Cancer Res Treat 6 (2007) 111-121
22. 18F-FET PET-guided delineation of target volumes in high-grade glioma patients. Eur J Nucl Med Mol Imaging 36 (2009) 182-193
23. Daisne J.-F., Sibomana M., Bol A., et al. Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: influence of reconstruction algorithms. Radiother Oncol 69 (2003) 247-250
24. Coakley F.V., Teh H.S., Qayyum A., et al. Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience. Radiology 233 (2004) 441-448
25. Oehr P., and Bouchelouche K. Imaging of prostate cancer. Curr Opin Oncol 19 (2007) 259-264
26. 18FDG-hybrid PET fusion. Int J Radiat Oncol Biol Phys 51 (2001) 923-931
27. van Baardwijk A., Bosmans G., Boersma L., et al. PET-CT-based auto-contouring in non-small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved nodal volumes. Int J Radiat Oncol Biol Phys 68 (2007) 771-778
28. Ward J.F., Sebo T.J., Blute M.L., and Zincke H. Salvage surgery for radiorecurrent prostate cancer: contemporary outcomes. J Urol 173 (2005) 1156-1160
29. Giraud P., Elles S., Helfre S., et al. Conformal radiotherapy for lung cancer: different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists. Radiother Oncol 62 (2002) 27-36
30. 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer. Int J Radiat Oncol Biol Phys 69 (2007) 1282-1289
31. Daisne J.F., Duprez T., Weynand B., et al. Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology 233 (2004) 93-100
32. Chun F.K., Briganti A., Jeldres C., et al. Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy. Eur J Cancer 43 (2007) 536-543
33. Kikuchi E., Scardino P.T., Wheeler T.M., Slawin K.M., and Ohori M. Is tumor volume an independent prognostic factor in clinically localized prostate cancer?. J Urol 172 (2004) 508-511
34. Pickett B., Vigneault E., Kurhanewicz J., Verhey L., and Roach M. Static field intensity modulation to treat a dominant intra-prostatic lesion to 90 Gy compared to seven field 3-dimensional radiotherapy. Int J Radiat Oncol Biol Phys 44 (1999) 921-929